Evidence map›Paper›PMID 29540195›Full record

ArticleArthritis research & therapy2018

Traditional Chinese medicine formula Bi-Qi capsule alleviates rheumatoid arthritis-induced inflammation, synovial hyperplasia, and cartilage destruction in rats.

Kai Wang, Dongmei Zhang, Yan Liu, Xuan Wang, Jiantong Zhao, Tingting Sun, Tingting Jin, Baoli Li, Janak L Pathak

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Fu-zi decoction attenuate rheumatoid arthritisFrontiers in pharmacology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Total Saponins fromBioMed research international · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kai WangDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Dongmei ZhangDepartment of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, 300070, China.
Yan LiuDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Xuan WangDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Jiantong ZhaoDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Tingting SunDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Tingting JinDepartment of International Medicine, Geriatric Disease Research Institute, Tianjin Hospital, Tianjin, 300211, China.
Baoli LiDepartment of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, 300070, China.
Janak L PathakSchool of Pharmaceutical Science and Technology, Health Sciences Platform, Tianjin University, Tianjin, 300072, China. j.pathak@tju.edu.cn.
Tianjin Hospital · CNTianjin Medical University General Hospital · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional Chinese medicine (TCM) formula Bi-Qi capsule (Bi-Qi) is a commonly prescribed drug to treat rheumatoid arthritis (RA). However, the mechanism of Bi-Qi-mediated amelioration of RA pathogenesis is still a mystery. Collagen induced arthritis (CIA) in rats is an established model that shares many similarities with RA in humans. In this study we investigated the effect of Bi-Qi on the pathogenesis of CIA in rats.

methodsCIA was developed in Sprague-Dawley (S.D) rats (n = 60, female) and used as a model resembling RA in humans. Rats were treated with a high or moderate dose of Bi-Qi, or methotrexate (MTX). Effects of the treatment on local joint and systemic inflammation, synovial hyperplasia, cartilage destruction, and other main features in the pathogenesis of CIA were analyzed.

resultsInflamed and swollen ankles and joints were observed in arthritic rats, while Bi-Qi or MTX treatment alleviated these symptoms. Only the Bi-Qi moderate dose decreased RA-induced serum levels of tumor necrosis factor-alpha (TNF-α). Both Bi-Qi and MTX reduced the interleukin (IL)-18 serum level. Protein levels of cartilage oligomeric matrix protein and osteopontin in serum, synovium, and cartilage were elevated in arthritic rats, while Bi-Qi alleviated these effects. Synovial hyperplasia, inflammatory cell infiltration in synovium and a high degree of cartilage degradation was observed in RA, and Bi-Qi or MTX alleviated this effect. Bi-Qi at the moderate dose was the most effective in mitigating CIA-related clinical complications.

conclusionsOur findings showed that Bi-Qi alleviates CIA-induced inflammation, synovial hyperplasia, cartilage destruction, and the other main features in the pathogenesis of CIA. This provides fundamental evidence for the anti-arthritic properties of Bi-Qi and corroborates the use of Bi-Qi TCM formula for the treatment of RA.

Indexed as

Medicine, Chinese TraditionalAnimalsArthritis, ExperimentalCartilageDrugs, Chinese HerbalFemaleHyperplasiaInflammationRatsRats, Sprague-DawleySynovial MembraneDrugs, Chinese HerbalBi-Qi-capsuleCartilage destructionInflammationMethotrexatePathogenesisRheumatoid arthritisSynovial hyperplasia

Identifiers

PMID29540195
PMCPMC5853033
OpenAlexW2801071713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.